Cargando…

Covid-19 vaccine effectiveness against general SARS-CoV-2 infection from the omicron variant: A retrospective cohort study

We aim to estimate the effectiveness of 2-dose and 3-dose mRNA vaccination (BNT162b2 and mRNA-1273) against general Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) infection (asymptomatic or symptomatic) caused by the omicron BA.1 variant. This propensity-score matched retrospective coh...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rennert, Lior, Ma, Zichen, McMahan, Christopher S., Dean, Delphine
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2023
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9910751/ https://www.ncbi.nlm.nih.gov/pubmed/36777314 http://dx.doi.org/10.1371/journal.pgph.0001111

Ejemplares similares

Effectiveness and protection duration of Covid-19 vaccines and previous infection against any SARS-CoV-2 infection in young adults
por: Rennert, Lior, et al.
Publicado: (2022)

Risk of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Reinfection in a University Student Population
por: Rennert, Lior, et al.
Publicado: (2021)

Surveillance-based informative testing for detection and containment of SARS-CoV-2 outbreaks on a public university campus: an observational and modelling study
por: Rennert, Lior, et al.
Publicado: (2021)

Vaccine Protection Against the SARS-CoV-2 Omicron Variant in Macaques
por: Chandrashekar, Abishek, et al.
Publicado: (2022)

Vaccine protection against the SARS-CoV-2 Omicron variant in macaques
por: Chandrashekar, Abishek, et al.
Publicado: (2022)

Vaccines Elicit Highly Cross-Reactive Cellular Immunity to the SARS-CoV-2 Omicron Variant
por: Liu, Jinyan, et al.
Publicado: (2022)

Reduced pathogenicity of the SARS-CoV-2 omicron variant in hamsters
por: McMahan, Katherine, et al.
Publicado: (2022)

Booster with Ad26.COV2.S or Omicron-adapted vaccine enhanced immunity and efficacy against SARS-CoV-2 Omicron in macaques
por: Solforosi, Laura, et al.
Publicado: (2023)

Vaccines elicit highly conserved cellular immunity to SARS-CoV-2 Omicron
por: Liu, Jinyan, et al.
Publicado: (2022)

Vaccination with Omicron Inactivated Vaccine in Pre-vaccinated Mice Protects against SARS-CoV-2 Prototype and Omicron Variants
por: Zhang, Yuntao, et al.
Publicado: (2022)

SARS-CoV-2 variants of concern Alpha and Delta show increased viral load in saliva
por: King, Kylie L., et al.
Publicado: (2022)

SARS-CoV-2 variants of concern Alpha and Delta show increased viral load in saliva
por: King, Kylie L., et al.
Publicado: (2022)

Modelling the impact of presemester testing on COVID-19 outbreaks in university campuses
por: Rennert, Lior, et al.
Publicado: (2020)

Effect of booster vaccination against Delta and Omicron SARS-CoV-2 variants in Iceland
por: Norddahl, Gudmundur L., et al.
Publicado: (2022)

Monovalent vaccination with inactivated SARS-CoV-2 BA.5 protects hamsters against Omicron but not non-Omicron variants
por: Ong, Chon Phin, et al.
Publicado: (2023)

Effectiveness of Inactivated COVID-19 Vaccines against COVID-19 Caused by the SARS-CoV-2 Delta and Omicron Variants: A Retrospective Cohort Study
por: Hua, Qiaoli, et al.
Publicado: (2022)

Rapid development of an updated mRNA vaccine against the SARS-CoV-2 Omicron variant
por: Zhang, Na-Na, et al.
Publicado: (2022)

Broadly neutralizing antibodies against Omicron-included SARS-CoV-2 variants induced by vaccination
por: Chi, Xiangyang, et al.
Publicado: (2022)

Neutralising reactivity against SARS-CoV-2 Delta and Omicron variants by vaccination and infection history
por: Lavezzo, Enrico, et al.
Publicado: (2022)

Development of a ferritin-based nanoparticle vaccine against the SARS-CoV-2 Omicron variant
por: Tai, Wanbo, et al.
Publicado: (2022)

Rapid decline in vaccine-boosted neutralizing antibodies against SARS-CoV-2 Omicron variant
por: Lyke, Kirsten E., et al.
Publicado: (2022)

Identification of vaccine candidate against Omicron variant of SARS-CoV-2 using immunoinformatic approaches
por: Aasim, et al.
Publicado: (2022)

Bioinformatics approach for the construction of multiple epitope vaccine against omicron variant of SARS-CoV-2
por: Zaib, Sumera, et al.
Publicado: (2022)

The impact of phased university reopenings on mitigating the spread of COVID-19: a modeling study
por: Rennert, Lior, et al.
Publicado: (2021)

Protection against SARS-CoV-2 Omicron BA.1 variant challenge in macaques by prime-boost vaccination with Ad26.COV2.S and SpFN
por: Yu, Jingyou, et al.
Publicado: (2022)

Effectiveness of Bivalent Omicron-Containing Booster Vaccines against SARS-CoV-2 Omicron Variant among Individuals with and without Prior SARS-CoV-2 Infection
por: Widyasari, Kristin, et al.
Publicado: (2023)

SARS‐CoV‐2 Omicron variant: Immune escape and vaccine development
por: Ao, Danyi, et al.
Publicado: (2022)

Omicron Variant of SARS-CoV-2: An Indian Perspective of Vaccination and Management
por: Chavda, Vivek P., et al.
Publicado: (2023)

Retention of Neutralizing Response against SARS-CoV-2 Omicron Variant in Sputnik V-Vaccinated Individuals
por: Lapa, Daniele, et al.
Publicado: (2022)

Antibody Avidity and Neutralizing Response against SARS-CoV-2 Omicron Variant after Infection or Vaccination
por: Dapporto, Francesca, et al.
Publicado: (2022)

mRNA booster vaccination protects aged mice against the SARS-CoV-2 Omicron variant
por: Nanishi, Etsuro, et al.
Publicado: (2022)

Booster COVID-19 vaccination against the SARS-CoV-2 Omicron variant: A systematic review
por: Du, Yuxuan, et al.
Publicado: (2022)

More data needed on efficacy and safety of monovalent vaccines against SARS-CoV-2 omicron variants
por: Monach, Paul A, et al.
Publicado: (2023)

SARS-CoV-2 Vaccine Effectiveness against Omicron Variant in Infection-Naive Population, Australia, 2022
por: Bloomfield, Lauren E., et al.
Publicado: (2023)

Vaccine-induced neutralizing antibodies against SARS-CoV-2 Omicron variant isolated in Osaka, Japan
por: Hiroi, Satoshi, et al.
Publicado: (2023)

Repeated vaccination of inactivated SARS-CoV-2 vaccine dampens neutralizing antibodies against Omicron variants in breakthrough infection
por: Gao, Bo, et al.
Publicado: (2023)

Immunogenicity of Ad26.COV2.S vaccine against SARS-CoV-2 variants in humans
por: Alter, Galit, et al.
Publicado: (2021)

An epidemiological modeling framework to inform institutional-level response to infectious disease outbreaks: A Covid-19 case study
por: Rennert, Lior, et al.
Publicado: (2023)

Antibody response against SARS-CoV-2 variants of concern in children infected with pre-Omicron variants: An observational cohort study
por: Seery, Vanesa, et al.
Publicado: (2022)

Protection against the Omicron Variant from Previous SARS-CoV-2 Infection
por: Altarawneh, Heba N., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_0i9mokghs9uukj05k35stqef37